204 related articles for article (PubMed ID: 28625359)
1. Roles of Arf6 in cancer cell invasion, metastasis and proliferation.
Li R; Peng C; Zhang X; Wu Y; Pan S; Xiao Y
Life Sci; 2017 Aug; 182():80-84. PubMed ID: 28625359
[TBL] [Abstract][Full Text] [Related]
2. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
3. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs.
Yamauchi Y; Miura Y; Kanaho Y
Adv Biol Regul; 2017 Jan; 63():115-121. PubMed ID: 27776975
[TBL] [Abstract][Full Text] [Related]
4. Arf6 promotes cell proliferation via the PLD-mTORC1 and p38MAPK pathways.
Knizhnik AV; Kovaleva OV; Komelkov AV; Trukhanova LS; Rybko VA; Zborovskaya IB; Tchevkina EM
J Cell Biochem; 2012 Jan; 113(1):360-71. PubMed ID: 21928324
[TBL] [Abstract][Full Text] [Related]
5. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.
Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H
Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281
[TBL] [Abstract][Full Text] [Related]
6. [Small RNA interference-mediated ADP-ribosylation factor 6 silencing inhibits proliferation, migration and invasion of human prostate cancer PC-3 cells].
Shan XW; Lv SD; Yu XM; Hu ZF; Zhang JJ; Wang GF; Wei Q
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):735-43. PubMed ID: 27320871
[TBL] [Abstract][Full Text] [Related]
7. Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis.
Hongu T; Yamauchi Y; Funakoshi Y; Katagiri N; Ohbayashi N; Kanaho Y
Small GTPases; 2016 Apr; 7(2):47-53. PubMed ID: 26909552
[TBL] [Abstract][Full Text] [Related]
8. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
[TBL] [Abstract][Full Text] [Related]
9. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.
Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y
Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474
[TBL] [Abstract][Full Text] [Related]
10. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
[TBL] [Abstract][Full Text] [Related]
11. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway.
Tague SE; Muralidharan V; D'Souza-Schorey C
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9671-6. PubMed ID: 15210957
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway.
Hu B; Shi B; Jarzynka MJ; Yiin JJ; D'Souza-Schorey C; Cheng SY
Cancer Res; 2009 Feb; 69(3):794-801. PubMed ID: 19155310
[TBL] [Abstract][Full Text] [Related]
13. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation.
Bourmoum M; Charles R; Claing A
PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355
[TBL] [Abstract][Full Text] [Related]
14. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
Marchesin V; Montagnac G; Chavrier P
PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
[TBL] [Abstract][Full Text] [Related]
15. ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Yu X; Xu J
Cancer Lett; 2017 Mar; 388():303-311. PubMed ID: 28025100
[TBL] [Abstract][Full Text] [Related]
16. P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
Hashimoto A; Oikawa T; Hashimoto S; Sugino H; Yoshikawa A; Otsuka Y; Handa H; Onodera Y; Nam JM; Oneyama C; Okada M; Fukuda M; Sabe H
J Cell Biol; 2016 Apr; 213(1):81-95. PubMed ID: 27044891
[TBL] [Abstract][Full Text] [Related]
17. ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.
Dani N; Barbosa AJ; Del Rio A; Di Girolamo M
Curr Pharm Des; 2013; 19(4):624-33. PubMed ID: 23016858
[TBL] [Abstract][Full Text] [Related]
18. Requirement for Arf6 in breast cancer invasive activities.
Hashimoto S; Onodera Y; Hashimoto A; Tanaka M; Hamaguchi M; Yamada A; Sabe H
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6647-52. PubMed ID: 15087504
[TBL] [Abstract][Full Text] [Related]
19. ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion.
Marchesin V; Castro-Castro A; Lodillinsky C; Castagnino A; Cyrta J; Bonsang-Kitzis H; Fuhrmann L; Irondelle M; Infante E; Montagnac G; Reyal F; Vincent-Salomon A; Chavrier P
J Cell Biol; 2015 Oct; 211(2):339-58. PubMed ID: 26504170
[TBL] [Abstract][Full Text] [Related]
20. Investigating the role of ADP-ribosylation factor 6 in tumor cell invasion and extracellular signal-regulated kinase activation.
Hoover H; Muralidharan-Chari V; Tague S; D'Souza-Schorey C
Methods Enzymol; 2005; 404():134-47. PubMed ID: 16413265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
